A new procedure for measuring cyclosporine in plasma has been introduced by Abbott Laboratories, involving their TDx instrumentation and fluorescence polarization immunoassay. Radioimmunoassay (RIA) and high-performance liquid chromatography are currently the conventional methods for measuring cyclosporine in plasma and whole blood. In an effort to find a method that will decrease the radioactive hazard, the reagent and supply cost, and the labor requirements associated with RIA procedures, we used specimens from transplantation patients to compare the Abbott assay with the Sandoz Sandimmune' assay. We believe that the Abbott assay offers some advantages over the Sandimmune RIA procedure, providing a reliable but simpler and less hazardous technology.
The increase in organ transplantation and in patients receiving cyclosporine as part of immunosuppressive therapy has caused a dramatic increase in the number of laboratory requests for its assay (1) . The two technologies commonly used to evaluate cyclosporine are high-performance liquid chromatography (HPLC) and radioimmunoassay (RIA). Abbott Laboratories has recently introduced an assay that measures cyclosporine and its metabolites by fluorescence polarization immunoassay (FPIA), with the "TDx" instrumentation (2) .
At the University of Pitfsburgh School of Medicine, 4000 patients' specimens per month are analyzed in duplicate by the Sandoz "Sandimmune" assay for cyclosporine. The method measures the drug and some fraction of metabolites in either plasma or whole blood. A competitive proteinbinding ligand procedure, the Sandimmune RIA involves use of a tritiated antigen, which requires liquid scintillation spectrometry. The combination of radiolabeled materials and complex analytical techniques results in a variety of practical concerns: (a) radioactive hazard to personnel; (b) disposal of low-level radioactive waste; (c) expense and storage of reagents and disposables; (el) need for highly trained technical staff; (e) increased labor intensity from multiple handling steps; (j) lengthy incubation and counting processes; Igi complex and costly instrumentation, requiring significant space accommodations; and (h) relatively poor precision .
As the volume of cyclosporine analyses increases, the difficulties encountered in RIA procedures are magnified. We have evaluated the Abbott cyclosporine assay in order to more quickly provide results to clinicians and also to eliminate radioactive reagents from the laboratory. We analyzed 408 specimens along with more than 200 controls, in duplicate, by both the Abbott FPIA TDx method and the Sandimmune RIA. Results of this study indicate that values for cyclosporine measured by the FPIA TDx are higher than those determined by the Sandimmune RIA. The TDx meth-od, however, is more precise, easier, and highly reliable. In addition to rapid result reporting, the method provides a simple technology with few handling steps, compact instrumentation, and few reagent storage and disposal problems.
Materials and Methods
Sample collection. Samples, collected from each patient into tubes containing EDT A as anticoagulant, were allowed to equilibrate for 2 h at room temperature, then plasma was separated from the cells at room temperature after centrifugation. Temperature of the specimen during separation is an important factor, because the equilibration of cycJosporine with erythrocytes is temperature dependent (3) . No correction was made for hematocrit.
Procedures
RIA. Cyclosporine in plasma was measured by RIA with the Sandoz RIA kit according to the manufacturer's instructions (4) .
FPIA. Fluorescent polarization immunoassay with use of the Abbott TDx instrument is a recognized method for measurement of drugs and other constituents in body fluids (5-7). In the new procedure for cyclosporine, an antP iy is used that reacts both with cycIosporine and somt: A-its metabolites. We performed the assay according to the manufacturer's instructions.
The concentration range of the Abbott calibrators is 0 to 1000 ~/L. Specimens containing cycIosporine in concentrations > 1000 JJ,g/L were diluted with the zero calibrator (normal human serum) before the precipitation step, as were also specimens with background intensity> 1000. The manufacturer does not recommend a change in the background (MX BKGl setting.
Results
Cross-reacticity and." 'ci(icity. We tested cross-reactivity with compounds listed in Table 1 , whose concurrent ~ might interfere with the assay. Cross-reactivity was establIshed for a specimen by adding the test compound at a concentration of 100 mg/L, to drug-free pooled h~an serum, then assaying the specimen by the FPIA assay. The percentage cross-reactivity was calculated as: (me~sured cycJosporine and metabolites concentration divided by the concentration of the test compound) x 100. The compounds tested were all below the detection limit of the assay 1<15
Precision. Precision studies were performed on the Abbott low-, medium-, and high-concentration control sera (Tablp 2). All three control concentrations were included in ea,'l batch of 2(1. For the low control, 59 replicates were processed, yielding a coefficient of variation (CV) of 9.5% total and.7.4%-within-run; for the medium concentration, 60 replIcates for a total CV of 4.9% and within-run CV of2.9%; for the hIgh concentration, 61 replicates with a total CV of 4.4%-and within-run CV of 3.0%.
Precision of patients'-sample and control duplicates was excellent. Of about 600 specimens analyzed, only 10 samples Carryover. We saw no significant carryover from specimens with high concentrations.
Accuracy. Analytical recovery was tested with two sets of samples prepared by adding cyclosporine to give concentrations of 50, 75, 100. 200, 250, 500, and 700 ~!L to normal human serum and to normal human serum diluted fivefold in TDx Dilution Buffer. The TDx analyzer was calibrated with serum-based calibrators provided by the manufacturer. Both sets of specimens were determined in replicates of five and the results compared with the calibration curve ( Table  3 ). The average analytical recovery from diluted serum was 98.5% (SD 3.1%), from undiluted serum, 97.2% (SD 3.8%).
Comparison of methods. We received 408 specimens with requests for cyclosporine assays. These were used in the correlation studies. Plasma samples were prepared and processed by both the Sandoz Sandimmune RIA procedure and Abbott's cyclosporine and metabolites FPIA assay. Each sample was analyzed in duplicate and the values were averaged. On linear regression analysis comparing the two sets of results, the equation for the regression line was determined to be (1.72 :t 0.045%) + (61. 
Discussion
We found the Abbott TDx to be significantly more precise than the Sandimmune RIA. Coefficients of variation ranged from 4% to 10% for the TDx. Comparable values for the Sandimmune assay, which is in routine use in our laboratory, are 10% to 17%.
When our HPLC or RIA standards were run in the TDx, However, values for the TDx assay from patients' samples were about 1. 7 times the RIA values. This lack of correlation indicates that the two assays are not in fact measuring exactly the same thing. The Abbott antibody may react with a cyclosporine metabolite that is unreactive in the Sandoz assay system, or there may be a generally increased crossreactivity to all or to some subset of cyclosporine metabolites. In either case we believe this offers an advantage for the TDx assay, because recent observations from this insti- Ix \111'\ hod offers a simpler procedure with fewer I1l1dlllllo( sll'\ls lind fnl.'ter turnaround time. The instrumentutlon il>l 1II11t1l\\altoci and compact, allowing better use of ;SiMXk. £2£4 2 Ikchnologist time and laboratory space. Reagents and supplies present minimal storage and disposal problems and no radioactivity hazmd.
